Compare PAYO & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYO | NEOG |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | 2540 | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 1995 |
| Metric | PAYO | NEOG |
|---|---|---|
| Price | $7.04 | $9.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $7.69 | ★ $10.67 |
| AVG Volume (30 Days) | ★ 12.4M | 2.0M |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | $7.15 | N/A |
| Revenue Next Year | $10.28 | N/A |
| P/E Ratio | ★ $30.36 | $459.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.08 | $4.56 |
| 52 Week High | $7.67 | $11.43 |
| Indicator | PAYO | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 79.17 | 56.69 |
| Support Level | $4.78 | $8.86 |
| Resistance Level | N/A | $9.50 |
| Average True Range (ATR) | 0.23 | 0.35 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 95.70 | 83.82 |
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.